ArticleOncogene2020

Targeting the TR4 nuclear receptor-mediated lncTASR/AXL signaling with tretinoin increases the sunitinib sensitivity to better suppress the RCC progression.

Hangchuan Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.